The path to optimisation in pharmaceutical microbiology
Supported by:
4 December 2024
3:00pm
Shares
- Like
- Digg
- Del
- Tumblr
- VKontakte
- Buffer
- Love This
- Odnoklassniki
- Meneame
- Blogger
- Amazon
- Yahoo Mail
- Gmail
- AOL
- Newsvine
- HackerNews
- Evernote
- MySpace
- Mail.ru
- Viadeo
- Line
- Comments
- Yummly
- SMS
- Viber
- Telegram
- Subscribe
- Skype
- Facebook Messenger
- Kakao
- LiveJournal
- Yammer
- Edgar
- Fintel
- Mix
- Instapaper
- Copy Link
During this virtual panel, industry experts will delve into the latest advances and biggest challenges in pharmaceutical microbiology today.
During this virtual panel, industry experts will explore the latest advances in pharmaceutical microbiology, discuss key obstacles within the sector and how these can be overcome, as well as the approaches needed to facilitate a thriving future for the industry.
Spanning multiple areas, pharmaceutical microbiology ultimately ensures that drugs received by patients are as safe and effective as possible. Due to the complexity of the sector, it is important that microbiologists have a clear understanding of key strategies that guide their work, enabling them to effectively manage problems when they arise.
In an industry faced with continual change, to deliver optimal results, it is crucial for professionals working in the microbiology laboratory, manufacturing and beyond, to be equipped with the latest skills and techniques.
Similarly, with regulation and quality being essential considerations in the field for wider companies and personnel alike, staying abreast of the latest developments in pharmaceutical microbiology supports the overall industry to navigate hurdles that are encountered.
In this session, speakers will offer their expertise, highlighting critical considerations around compliance, validation and more. They will discuss emerging industry developments, recommendations around best practice, alongside effective methods for managing sterility, contamination and more.
Find out about the latest trends and developments and main challenges impacting the pharmaceutical microbiology sector in 2024
Learn about the fundamental approaches in pharmaceutical microbiology that support compliance, quality control and product safety, and get the opportunity to ask questions on key topics.
Hear from industry experts on best practice in key areas such as manufacturing, regulation drug development and more.
OUR SPEAKERS
Liz Brockson is an Aseptic Processing and Sterility Assurance Lead in Global Sterility Assurance and Microbiology at Takeda and is based out of Minneapolis, MN. Liz has a background in benchtop microbiology and immunology, as well as over 10 years of experience in FDA-regulated businesses as a quality assurance and quality control technical professional. In her current role, Liz is responsible for leading the design and implementation of Takeda’s global manufacturing sterility assurance program. Liz holds a Bachelor’s degree in Animal Sciences and a Master’s degree in Public Health, both from The Ohio State University.
FAQs
FAQs
Is the webinar free?
Yes – there is no charge to watch the webinar, either live or on-demand.
. How long will the webinar be?
This webinar will last up to an hour.
What do I need to watch this webinar?
All you need is a computer with an internet connection. We recommend using headphones if possible if you’re in an office environment.
